Page 66 - Clinical Olfactory Working Group Consensus Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical olfactory working group consensus statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Olfactory Working Group Consensus Statement Today - Breaking & Trending Today

Russia registers 20,538 Covid-19 cases in last 24 hours | India News


File photo
MOSCOW: Russia recorded 20,538 Covid-19 cases in the past 24 hours, down from 21,665 the day before, while the total number reached 5,451,291, the federal response center said on Sunday.
Over the past day, 20,538 Covid-19 cases were confirmed across 85 Russian regions, including 2,964 cases (14.4%) without clinical symptoms, the statement said.
Moscow confirmed 6,723 daily infections, down from 8,457 the day before. The Russian capital was followed by the Moscow region with 2,608 cases, up from 2,504 the day before, and St. Petersburg with 1,298 cases, up from 1,247 cases the day before.
The response center said that there were 599 new fatalities linked to the coronavirus, down from 619 the day before, raising the country s death toll to 133,282. ....

Sankt Peterburg , Ndia News , Ndia News Today , Oday News , Google News , Reaking News , St Petersburg , Covid 19 Cases , ஸ்டம்ப் பீட்டர்ஸ்பர்க் ,

[종합]셀트리온 "렉키로나, 경증 환자로 투약 범위 확대"…임상 3상 탑라인 발표


[종합]셀트리온 렉키로나, 경증 환자로 투약 범위 확대 …임상 3상 탑라인 발표
입력 2021-06-14 11:06
▲렉키로나 (사진제공=셀트리온)
셀트리온이 코로나19 치료제 ‘렉키로나’에 대한 임상 3상 결과 탑라인에서 유효성과 안전성을 확인했다. 이번 임상 3상은 임상 2상과 달리 1315명의 대규모 피험자를 대상으로 임상을 진행했고, 고령ㆍ기저질환 동반의 고위험군 환자와 전체 환자에게서 모두 통계적 유의성을 입증한 만큼 셀트리온은 기존 중증 환자에게 제한됐던 렉키로나 투약 범위를 경증 환자로 확대한다는 의지를 밝혔다. 아울러 이번 결과를 바탕으로 미국 식품의약국(FDA), 유럽의약품청(EMA) 등 글로벌 규제기관에 정식 허가를 요청한다는 계획이다.
14일 셀트리온에 따르면 1월부터 한국, 미국, 스페인, 루마니아 등 ....

United States , South Korea , Kim Seong Hyun Celltrion , Drug Administration , Celltrion Clinical , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா ,